PRODUCTS
Products for Health Care Practitioner
Therapeutic Areas
Nordic Pharma has a range of proprietary and in-licensed products in the following therapeutic areas: Rheumatology, Women’s Health, Critical Care, Respiratory, Orphan Drugs and Biosimilars.
Rheumatology
Nordimet® Pre-Filled Syringe (PFS)
Nordimet® Pre-Filled Syringe (PFS)
Nordimet® PFS is indicated for the treatment of active rheumatoid arthritis in adult patients, polyarthritic forms of severe, active juvenile idiopathic arthritis (JIA), when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate, severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, psoralens and ultraviolet A (PUVA), and retinoids, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent Crohn’s disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.
Available in Romania, Greece and Cyprus.
Nordimet® Auto-Injector (AI)
Nordimet® Auto-Injector (AI)
Nordimet® AI is indicated for the treatment of active rheumatoid arthritis in adult patients, polyarthritic forms of severe, active juvenile idiopathic arthritis (JIA), when the response to nonsteroidal anti-inflammatory drugs (NSAIDs) has been inadequate, severe recalcitrant disabling psoriasis, which is not adequately responsive to other forms of therapy such as phototherapy, psoralens and ultraviolet A (PUVA), and retinoids, and severe psoriatic arthritis in adult patients, induction of remission in moderate steroid-dependent Crohn’s disease in adult patients, in combination with corticosteroids and for maintenance of remission, as monotherapy, in patients who have responded to methotrexate.
Available in Czech Republic.
Keplat®
Keplat®
Keplat® is topical pain patch for the symptomatic relief of pain and inflammation associated with acute musculoskeletal difficulties, such as trauma, sprain and contusion as well as muscle pain, stiffness, joint pain and pain of lumbar spine.
Keplat® contains pain fighting ingredients, ketoprofen (a NSAID – a nonsteroidal anti-inflammatory drug with analgesic and antipyretic effects).
Available only in Czech Republic.
Ibuprofen Amring®
Ibuprofen Amring®
Ibuprofen Amring® is an ibuprofen drug.
Pharmacotherapeutic group: non-steroidal anti-inflammatory drugs
Ibuprofen Amring® is indicated for adults and adolescents weighing more than 40 kg and over 12 years old in: pain of mild to moderate intensity, primary dysmenorrhea, fever, rheumatic diseases such as arthritic diseases, for example: rheumatoid arthritis, diseases degenerative arthritis (eg osteoarthritis), rheumatic joint disease, other muscle and joint disorders, and soft tissue disorders.
Available in Romania only.
Women’s Health
Mifegyne®
Mifegyne®
Mifegyne® is a mifepristone drug used for: medical termination of developing intra-uterine pregnancy, softening and dilatation of the cervix uteri prior to surgical termination of pregnancy during the first trimester, preparation for the action of prostaglandin analogues in the termination of pregnancy for medical reasons and labor induction in fetal death in utero.
Available In Romania, Czech Republic, Greece, Cyprus, Bulgaria, Croatia, Slovenia, South Africa.
Mifepristone Linepharma®
Mifepristone Linepharma®
Mifepristone Linepharma® is recommended for: the medical termination of a pregnancy (no later than 63 days after the first day of your last period), in combination with another treatment called prostaglandin, for softening and opening the cervix before surgical termination of pregnancy during the first trimester, for use in combination with prostaglandins for termination of pregnancy for medical reasons beyond 3 months gestation and to induce labor in cases where the fetus has died in the womb and where it is not possible to use other medical treatments.
Available only in South Africa.
Mispregnol®/TopoGyne®
Mispregnol®/TopoGyne®
Mispregnol®/TopoGyne® is a prostaglandin used for medical termination of developing intra-uterine pregnancy, in sequential use with mifepristone, up to 49 days of amenorrhea and for cervix uteri preparation prior to surgical termination of pregnancy during the first trimester.
TopoGyne® is available in Romania, Bulgaria, Slovenia. Mispregnol is available on Czech Republic, and Croatia.
Hyalobarrier®
Hyalobarrier® Gel/Hyalobarrier® Gel Endo
Hyalobarrier® is natural hyaluronic acid used for the prevention or reduction of post-surgical adhesion formation in the abdomino-pelvic area. Hyalobarrier® Gel is indicated for use in open surgery procedures. Hyalobarrier® Gel Endo is indicated for use in laparoscopic and hysteroscopic surgical procedures. Hyalobarrier® is a Class III medical Devices.
Available in Romania, Bulgaria, Czech Republic, Slovakia, Hungary, Croatia and Slovenia.
Critical Care
Trasylol®
Trasylol®
Trasylol® is a drug containing aprotinin, indicated for prophylactic use to reduce blood loss and blood transfusion in adult patients who are at high risk of major blood loss undergoing isolated cardiopulmonary bypass graft surgery (i.e. coronary artery bypass graft surgery that is not combined with other cardiovascular surgery).
Trasylol® is available in Romania, Poland, Hungary, Greece.
Teysuno®
Teysuno®
Teysuno® belongs to a group of cancer medicines called fluoropyrimidines and is used to treat advanced gastric (stomach) cancer together with cisplatin. It is also used to treat metastatic colorectal cancer (cancer of the colon and rectum that has spread elsewhere in the body) in patients who can no longer be treated with other fluoropyrimidines because of unacceptable side effects. For this it may be used alone or with the cancer medicines oxaliplatin or irinotecan, with or without another medicine, bevacizumab. Teysuno® contains the active substances tegafur, gimeracil and oteracil.
Teysuno® is available in Czech Republic, Hungary, Slovenia and Greece.
Profast®/Propofol Amring®
Profast®/Propofol Amring®
Profast®/Propofol Amring® is a propofol drug.
Therapeutical class: general anesthetics.
Profast®/Propofol Amring® is a short-acting general anesthetic for intravenous use in: induction and maintenance of general anesthesia in adults and children > 1 month of age; sedation during diagnostic and surgical procedures, alone or in combination with local or regional anesthesia in adults and children> 1 month of age; sedation of ventilated patients> 16 years of age in intensive care units.
Profast® is available in Romania only and Propofol Amring® is available in African countries only.
Fluconazole Amring®
Fluconazole Amring®
Fluconazole Amring® is a fluconazole drug.
Therapeutical class: imidazole – and triazole antifungals
Fluconazole Amring® is indicated in adults for the treatment of Cryptococcal meningitis, Coccidioidomycosis, Invasive candidiasis, Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis, Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient.
Fluconazole Amring® is indicated in adults for the prophylaxis of: Relapse of crytopcoccal meningitis in patients with high risk of recurrence, Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse, Prophylaxis of candidal infections in patients with prolonged neutropenia (such as patients with haematological malignancies receiving chemotherapy or patients receiving Hematopoietic Stem Cell Transplantation.
Fluconazole Amring® is indicated in term newborn infants, infants, toddlers, children and adolescents aged from 0 to 17 years old for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningitis and the prophylaxis of candidal infections in immunocompromised patients. Fluconazole Amring® can be used as maintenance therapy to prevent relapse of cryptococcal meningitis in children with high risk of reoccurrence.
Available in African countries only.
Paracetamol Amring®
Paracetamol Amring®
Paracetamol Amring® is a acetaminophen drug indicated for the short-term treatment of moderate pain, especially following surgery and for the short-term treatment of fever, when administration by intravenous route is clinically justified by an urgent need to treat pain or hyperthermia and/or when other routes of administration are nor possible.
Available in African countries only.
Midazolam Baxter®
Midazolam Baxter®
Midazolam Baxter® is a midazolam drug.
Pharmacotherapeutic group: benzodiazepines.
Midazolam is a short-acting sleep inducer indicated for:
In adults: Sedation before and during the diagnostic or therapeutical procedures, with or without local anesthesia, anesthesia (premedication before induction of general anesthesia, induction of anesthesia, as a sedative component in combined anesthesia), sedation in intensive care units.
At Children: Sedation before and during the diagnostic or therapeutical procedures, with or without local anesthesia, anesthesia (premedication before induction of general anesthesia), sedation in intensive care units.
Available in Romania only.
Respiratory
Serroflo®
Serroflo®
Serroflo® is a combination of two drugs: Salmeterol (bronchodilator) and Fluticasone propionate (corticosteroid).
Serroflo® is indicated in the background treatment of asthma, where appropriate use of a combination of active substances (long-acting beta-2-agonist and corticosteroid with inhalation administration): patients who are not adequately controlled on inhaled corticosteroids, and short-acting beta-2-agonist, “as needed” or patients who are already adequately controlled on both inhaled corticosteroids and long-acting beta-2-agonists.
Available in Romania only.
Soprobec®
Soprobec®
Soprobec® is a beclometasone dipropionate drug.
Therapeutical class: corticosteroids
Soprobec® is used as maintenance treatment of asthma when the use of pressurized metered dose inhaler is appropriate.
Available in Romania only.
Arquist®
Arquist®
Arquist® is a fluticasone drug.
Therapeutical class: corticosteroids
Arquist® is indicated for the treatment of asthma in adults and adolescents over 16 years of age. Arquist® is also indicated for the treatment of severe COPD when used in combination with a long-acting beta-agonist (such as salmeterol) in adults.
Available in Romania only.
Ipravent®
Ipravent®
Ipravent® is an ipratropium bromide drug.
Therapeutical class: Anticholinergics
Ipratropium bromide is indicated for the treatment of reversible bronchospasm associated with chronic obstructive pulmonary disease (COPD). Ipratropium bromide is indicated for the treatment of reversible airway obstruction in asthma, especially in patients with a poor response to β2-adrenergic stimulants, those with contraindications to these and those with chronic asthma.
Available in Romania only.
Zerostat Vt Spacer®
Zerostat Vt Spacer®
Zerostat Vt Spacer® is a medical device that is used in combination with an inhaler, favoring the more efficient administration, directly in the lungs, of the drugs recommended in asthma. Zerostat VT Spacer®, also known as an inhalation chamber, keeps the medicine for a few seconds after it is released and facilitates inhalation by improving breathing coordination.
Baby Mask®
Baby Mask®
Baby Mask® is a medical device designed to make administration of the inhaled bronchodilators & anti-inflammatory drugs to the lungs through the metered-dose inhaler (MDI) & Zerostat VT Spacer® easier for infants & children below 3 years. The Baby Mask® helps children attain the full benefit of the medicine released by the inhaler and can also easily inhale the medicine without any hassles.
Huf Puf kit®
Huf Puf kit®
Huf Puf kit® is a ready-to-use kit that includes Baby Mask® and Zerostat Vt Spacer® in a box that looks attractive to children.
Orphan Drugs
Amglidia®
Amglidia®
Amglidia® is indicated for the treatment of neonatal diabetes mellitus, for use in newborns, infants and children. Is the only liquid form drug containing glibenclamide and is easy to be administrated in children.
Biosimilars
Bevacizumab Amring®
Bevacizumab Amring®
Bevacizumab Amring® is a bevacizumab drug. The bio similarity programs of Bevacizumab Amring have confirmed similar pharmacokinetic profile and similar effectiveness, safety and immunogenicity in comparison with the original products.
Therapeutical class: antineoplastics
Bevacizumab is used in combination with fluoropyrimidine-based chemotherapy and is indicated for treatment of adult patients with metastatic carcinoma of the colon or rectum.
Bevacizumab in combination with paclitaxel is indicated for first-line treatment of adult patients with metastatic breast cancer.
Bevacizumab in combination with capecitabine is indicated for first-line treatment of adult patients with metastatic breast cancer in whom treatment with other chemotherapy options including taxanes or anthracyclines is not considered appropriate.
Bevacizumab, in addition to platinum-based chemotherapy, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-small cell lung cancer other than predominantly squamous cell histology.
Bevacizumab, in combination with erlotinib, is indicated for first-line treatment of adult patients with unresectable advanced, metastatic or recurrent non-squamous non-small cell lung cancer with Epidermal Growth Factor Receptor (EGFR) activating mutations.
Bevacizumab in combination with interferon alfa-2a is indicated for first line treatment of adult patients with advanced and/or metastatic renal cell cancer.
Bevacizumab, in combination with carboplatin and paclitaxel is indicated for the front-line treatment of adult patients with advanced (International Federation of Gynecology and Obstetrics (FIGO) stages III B, III C and IV) epithelial ovarian, fallopian tube, or primary peritoneal cancer
Bevacizumab, in combination with carboplatin and gemcitabine or in combination with carboplatin and paclitaxel, is indicated for treatment of adult patients with first recurrence of platinum-sensitive epithelial ovarian, fallopian tube or primary peritoneal cancer who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor–targeted agents.
Bevacizumab in combination with paclitaxel, topotecan, or pegylated liposomal doxorubicin is indicated for the treatment of adult patients with platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer who received no more than two prior chemotherapy regimens and who have not received prior therapy with bevacizumab or other VEGF inhibitors or VEGF receptor–targeted agents.
Bevacizumab, in combination with paclitaxel and cisplatin or, alternatively, paclitaxel and topotecan in patients who cannot receive platinum therapy, is indicated for the treatment of adult patients with persistent, recurrent, or metastatic carcinoma of the cervix.
Available in African countries.
Rituximab Amring®
Rituximab Amring®
Rituximab Amring® is a rituximab drug. The bio similarity programs of Rituximab Amring® have confirmed similar pharmacokinetic profile and similar effectiveness, safety and immunogenicity in comparison with the original products.
Therapeutical class: antineoplastics
Rituximab Amring® indicated for adult subjects suffering from the following conditions: non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis, granulomatosis with polyangiitis and microscopic polyangiitis
Available in African countries.
Other Products
Paravit® – CF Capsules
Paravit® – CF Capsules
Paravit® – CF is a Food for Special Medical Purposes. For the dietary management of patients with cystic brosis. Paravit® – CF contains higher amounts of fat-soluble vitamins than regular food supplements.
Paravit® – CF
Paravit® – CF
Vitamin liquid formula
Paravit® – CF liquid is a Food for Special Medical Purposes. For the dietary management of patients with cystic brosis. Paravit® – CF contains higher amounts of fat-soluble vitamins than regular food supplements.
Partnerships